Richard H. Tullis
Plus aucun poste en cours
Profil
Richard H.
Tullis was the founder of Synthetic Genetics (1985) where he held the title of President & Chief Executive Officer.
He is also the founder of Molecular Biosystems, Inc. Dr. Tullis's former jobs include Interim Chief Executive Officer at Genetic Vectors, Inc. and Director at Verthermia, Inc. He was also the Chief Scientific Officer at Aethlon Medical, Inc. from 2000 to 2016.
Dr. Tullis earned a doctorate degree from the University of California San Diego.
Anciens postes connus de Richard H. Tullis
| Sociétés | Poste | Fin |
|---|---|---|
| AETHLON MEDICAL, INC. | Directeur Technique/Scientifique/R&D | 09/02/2016 |
Verthermia, Inc.
 Verthermia, Inc. Miscellaneous Commercial ServicesCommercial Services Verthermia, Inc. develops cancer treatment which induces Whole Body Hyperthermia (WBHT) by directly heating circulating blood. It specializes in medical devices and cancer therapy. The company was founded in 2012 and is headquartered in San Jose, CA. | Directeur/Membre du Conseil | - |
Genetic Vectors, Inc.
 Genetic Vectors, Inc. Pharmaceuticals: MajorHealth Technology Genetic Vectors, Inc. is a biotechnology company, which supplies genetic engineering tools and analytical kits to the biotechnology and molecular biology markets. Its products allow biopharmaceutical companies to test for biopharmaceutical product purity in compliance with regulatory standards. The company is currently marketing the EpiDNA product line as a quality control tool for the biopharmaceutical industry. Its EasyID genetic screening products are designed to study disease risk assessment, drug resistance, and drug responsiveness. The company was founded by Mead M. McCabe on December 28, 1991 and is headquartered in Aventura, FL. | President | - |
Synthetic Genetics
 Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Fondateur | - |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Fondateur | - |
Formation de Richard H. Tullis
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AETHLON MEDICAL, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Genetic Vectors, Inc.
Genetic Vectors, Inc. Pharmaceuticals: MajorHealth Technology Genetic Vectors, Inc. is a biotechnology company, which supplies genetic engineering tools and analytical kits to the biotechnology and molecular biology markets. Its products allow biopharmaceutical companies to test for biopharmaceutical product purity in compliance with regulatory standards. The company is currently marketing the EpiDNA product line as a quality control tool for the biopharmaceutical industry. Its EasyID genetic screening products are designed to study disease risk assessment, drug resistance, and drug responsiveness. The company was founded by Mead M. McCabe on December 28, 1991 and is headquartered in Aventura, FL. | Health Technology |
Synthetic Genetics
Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Commercial Services |
Verthermia, Inc.
Verthermia, Inc. Miscellaneous Commercial ServicesCommercial Services Verthermia, Inc. develops cancer treatment which induces Whole Body Hyperthermia (WBHT) by directly heating circulating blood. It specializes in medical devices and cancer therapy. The company was founded in 2012 and is headquartered in San Jose, CA. | Commercial Services |